NO20001847L - New use of compounds for anti-itch activity - Google Patents

New use of compounds for anti-itch activity

Info

Publication number
NO20001847L
NO20001847L NO20001847A NO20001847A NO20001847L NO 20001847 L NO20001847 L NO 20001847L NO 20001847 A NO20001847 A NO 20001847A NO 20001847 A NO20001847 A NO 20001847A NO 20001847 L NO20001847 L NO 20001847L
Authority
NO
Norway
Prior art keywords
compounds
new use
itch activity
itch
activity
Prior art date
Application number
NO20001847A
Other languages
Norwegian (no)
Other versions
NO20001847D0 (en
Inventor
Don Edgar Griswold
Iv Siegfried Benja Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20001847D0 publication Critical patent/NO20001847D0/en
Publication of NO20001847L publication Critical patent/NO20001847L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20001847A 1997-10-17 2000-04-10 New use of compounds for anti-itch activity NO20001847L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
NO20001847D0 NO20001847D0 (en) 2000-04-10
NO20001847L true NO20001847L (en) 2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001847A NO20001847L (en) 1997-10-17 2000-04-10 New use of compounds for anti-itch activity

Country Status (18)

Country Link
EP (1) EP1030666A4 (en)
JP (1) JP2001520196A (en)
KR (1) KR20010031149A (en)
CN (1) CN1306426A (en)
AR (1) AR015966A1 (en)
AU (1) AU740875B2 (en)
BR (1) BR9814080A (en)
CA (1) CA2306985A1 (en)
CO (1) CO4810374A1 (en)
CZ (1) CZ20001376A3 (en)
HU (1) HUP0003792A3 (en)
IL (1) IL135581A0 (en)
NO (1) NO20001847L (en)
NZ (1) NZ503551A (en)
PL (1) PL341062A1 (en)
TR (1) TR200001040T2 (en)
WO (1) WO1999020280A1 (en)
ZA (1) ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12541A (en) 2001-01-31 2006-06-05 Pfizer Prod Inc Ether derivatives useful as inhibitors of PDE4 isozymes.
EA200300622A1 (en) 2001-01-31 2003-12-25 Пфайзер Продактс Инк. DERIVATIVES OF AMIDES TIAZOLYL-, OXAZOLYL, PYRROLYL-AND IMIDAZOZYL ACID, USEFUL AS AN INHIBITORS OF PDE4 ISOFERMENT
NZ526453A (en) 2001-01-31 2005-01-28 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
EP1647274A4 (en) * 2003-07-17 2008-12-10 Ono Pharmaceutical Co Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (en) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
JP2005187458A (en) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
SG157242A1 (en) 2004-02-14 2009-12-29 Smithkline Beecham Corp Medicaments with hm74a receptor agonist activity
JP2008137892A (en) * 2005-03-04 2008-06-19 Eisai Co Ltd Antipruritic agent
BRPI0614270A2 (en) 2005-08-10 2011-03-22 Smithkline Beecham Corp xanthine derivatives as selective ha74a agonists
CN101389612B (en) * 2006-02-21 2011-09-21 卫材R&D管理有限公司 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
TWI404709B (en) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2008215411B2 (en) 2007-02-16 2012-11-22 Eisai R & D Management Co., Ltd. Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
US8513269B2 (en) 2007-08-17 2013-08-20 Eisai R&D Management Co., Ltd. Preparation for external use
WO2009025238A1 (en) 2007-08-17 2009-02-26 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
JP5985475B2 (en) * 2011-06-28 2016-09-06 田辺三菱製薬株式会社 New pharmaceutical composition
CA2973746C (en) 2015-01-30 2020-03-24 Shanton Pharma Co., Ltd. Prevention or treatment of uratic or gouty diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148170T3 (en) * 1990-12-21 2000-10-16 Beecham Group Plc XANTINA DERIVATIVES.
PT889886E (en) * 1996-03-26 2003-02-28 Altana Pharma Ag NEW FENANTRIDINES REPLACED IN POSITION 6
EP0912568B1 (en) * 1996-05-15 2002-11-20 ALTANA Pharma AG imidazopyridines
ATE248167T1 (en) * 1997-03-07 2003-09-15 Altana Pharma Ag TETRAZOLE DERIVATIVES
EP0998300A1 (en) * 1997-03-18 2000-05-10 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
AU8106598A (en) * 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
IL135581A0 (en) 2001-05-20
EP1030666A4 (en) 2002-10-16
WO1999020280A1 (en) 1999-04-29
NO20001847D0 (en) 2000-04-10
TR200001040T2 (en) 2001-01-22
PL341062A1 (en) 2001-03-26
CA2306985A1 (en) 1999-04-29
HUP0003792A3 (en) 2001-12-28
AU1093899A (en) 1999-05-10
NZ503551A (en) 2002-05-31
CO4810374A1 (en) 1999-06-30
JP2001520196A (en) 2001-10-30
CN1306426A (en) 2001-08-01
EP1030666A1 (en) 2000-08-30
CZ20001376A3 (en) 2002-06-12
AR015966A1 (en) 2001-05-30
AU740875B2 (en) 2001-11-15
HUP0003792A2 (en) 2001-10-28
BR9814080A (en) 2000-09-26
KR20010031149A (en) 2001-04-16
ZA989450B (en) 1999-04-19

Similar Documents

Publication Publication Date Title
CY2012029I2 (en) NEW FORM OF 5-OMEPRAZOLE
IS5354A (en) New compounds
ID24372A (en) COMPOUNDS OF 4-AMINO-TIAZOL-2-IL COMPOUNDS AS CDKERS
IS2027B (en) New Spiroasabicyclic Heterocyclic Compounds
FI972292A (en) Management of diabetes
ID24638A (en) COMPOUNDS OF ANTI ARYTHMIA BISPIDINA
NO20015855L (en) New use of compounds as antibacterial agents
NO20001847D0 (en) New use of compounds for anti-itch activity
NO993298L (en) New procedure
ID24677A (en) COMBINATION OF FUNICIDAL ACTIVE COMPOUNDS
ID29966A (en) SULFONYLOKSAZOLAMINA-SULFONYLOKSAZOLAMINA AS ACTIVE COMPOUNDS OF THERAPY
NO995796L (en) New procedure
ID24270A (en) REMOVAL OF KERATOTIC CONSTITIONS
FI963532A (en) New use of quinoline-3-carboxamide compounds
FI963531A0 (en) New use of quinoline-3-carboxamide compounds
ID24694A (en) USAGE OF SUBSTANCE AS CATALYST FOR THE MAKING OF CAPROLAKTAM
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID19787A (en) COMPOUND 25-HYDROXY-16-ENA-26,27-BISHOMO-COLLECTION OF FERROL
ID24521A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
NO963762D0 (en) New use of quinoline-3-carboxamide compounds
NO963764D0 (en) New use of quinoline-3-carboxamide compounds
SE9704839D0 (en) New compounds
SE9702696D0 (en) New compounds
SE9704838D0 (en) New compounds
SE9701220D0 (en) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application